Cencora, Inc.
CORNYSEHealthcare● Active
$274.08
$-0.96(-0.35%)
Market Cap$53.3B
P/E Ratio—
52W High$377.54
52W Low$244.82
Cencora, Inc.（COR）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · COR · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $1.57B | $1.52B | $1.75B | $1.67B | $1.54B |
| Depreciation & Amort. | $0.00B | $0.45B | $0.98B | $0.71B | $0.51B |
| Stock-Based Comp. | $0.00B | $0.15B | $0.12B | $0.09B | $0.10B |
| Change in Working Capital | $0.04B | $0.30B | $0.87B | ($0.14B) | $0.37B |
| Net Cash from Operations | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B |
| Investing Activities | |||||
| Capital Expenditure | ($0.67B) | ($0.49B) | ($0.46B) | ($0.50B) | ($0.44B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($4.98B) | ($0.62B) | ($2.60B) | ($0.37B) | ($6.14B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.44B) | ($1.49B) | ($1.18B) | ($0.48B) | ($0.08B) |
| Dividends Paid | ($0.44B) | ($0.42B) | ($0.40B) | ($0.39B) | ($0.37B) |
| Debt Issued / Repaid | $3.20B | ($0.39B) | ($0.62B) | ($0.92B) | $2.22B |
| Net Cash from Financing | $2.25B | ($2.33B) | ($2.22B) | ($1.75B) | $1.95B |
| Free Cash Flow | |||||
| Free Cash Flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
| FCF Margin %(computed) | 1.00% | 1.02% | 1.32% | 0.92% | 1.04% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Cencora, Inc.
关于Cencora, Inc.（COR）现金流量表
Cencora, Inc. 2025财年经营活动现金流$3.88B，自由现金流$3.21B（FCF利润率1.00%），资本支出($0.67B)。
常见问题
COR · 4 问Cencora, Inc. 2025财年自由现金流$3.21B，同比up7.0%。
COR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10